The global market for Needle Free Diabetes Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Needle Free Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle Free Diabetes Management.

The Needle Free Diabetes Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Needle Free Diabetes Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Needle Free Diabetes Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Needle Free Diabetes Management Market Report

Report Metric	Details
Report Name	Needle Free Diabetes Management Market
Segment by Type	Insulin Jet Injector Insulin Pen Insulin Inhaler Insulin Patch & Pump
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zogenix, 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies, Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Medtronic, Johnson & Johnson, Pancreum LLC, Tandem Diabetes Care, JDRF, Akra Dermojet
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Needle Free Diabetes Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Needle Free Diabetes Management Market report?

Ans: The main players in the Needle Free Diabetes Management Market are Zogenix, 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies, Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Medtronic, Johnson & Johnson, Pancreum LLC, Tandem Diabetes Care, JDRF, Akra Dermojet

What are the Application segmentation covered in the Needle Free Diabetes Management Market report?

Ans: The Applications covered in the Needle Free Diabetes Management Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Needle Free Diabetes Management Market report?

Ans: The Types covered in the Needle Free Diabetes Management Market report are Insulin Jet Injector, Insulin Pen, Insulin Inhaler, Insulin Patch & Pump

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Needle Free Diabetes Management Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Insulin Jet Injector

1.2.3 Insulin Pen

1.2.4 Insulin Inhaler

1.2.5 Insulin Patch & Pump

1.3 Market by Application

1.3.1 Global Needle Free Diabetes Management Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Needle Free Diabetes Management Market Perspective (2020-2031)

2.2 Global Needle Free Diabetes Management Growth Trends by Region

2.2.1 Global Needle Free Diabetes Management Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Needle Free Diabetes Management Historic Market Size by Region (2020-2025)

2.2.3 Needle Free Diabetes Management Forecasted Market Size by Region (2026-2031)

2.3 Needle Free Diabetes Management Market Dynamics

2.3.1 Needle Free Diabetes Management Industry Trends

2.3.2 Needle Free Diabetes Management Market Drivers

2.3.3 Needle Free Diabetes Management Market Challenges

2.3.4 Needle Free Diabetes Management Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Needle Free Diabetes Management Players by Revenue

3.1.1 Global Top Needle Free Diabetes Management Players by Revenue (2020-2025)

3.1.2 Global Needle Free Diabetes Management Revenue Market Share by Players (2020-2025)

3.2 Global Needle Free Diabetes Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Needle Free Diabetes Management Revenue

3.4 Global Needle Free Diabetes Management Market Concentration Ratio

3.4.1 Global Needle Free Diabetes Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Needle Free Diabetes Management Revenue in 2024

3.5 Global Key Players of Needle Free Diabetes Management Head office and Area Served

3.6 Global Key Players of Needle Free Diabetes Management, Product and Application

3.7 Global Key Players of Needle Free Diabetes Management, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Needle Free Diabetes Management Breakdown Data by Type

4.1 Global Needle Free Diabetes Management Historic Market Size by Type (2020-2025)

4.2 Global Needle Free Diabetes Management Forecasted Market Size by Type (2026-2031)

5 Needle Free Diabetes Management Breakdown Data by Application

5.1 Global Needle Free Diabetes Management Historic Market Size by Application (2020-2025)

5.2 Global Needle Free Diabetes Management Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Needle Free Diabetes Management Market Size (2020-2031)

6.2 North America Needle Free Diabetes Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Needle Free Diabetes Management Market Size by Country (2020-2025)

6.4 North America Needle Free Diabetes Management Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Needle Free Diabetes Management Market Size (2020-2031)

7.2 Europe Needle Free Diabetes Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Needle Free Diabetes Management Market Size by Country (2020-2025)

7.4 Europe Needle Free Diabetes Management Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Needle Free Diabetes Management Market Size (2020-2031)

8.2 Asia-Pacific Needle Free Diabetes Management Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Needle Free Diabetes Management Market Size by Region (2020-2025)

8.4 Asia-Pacific Needle Free Diabetes Management Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Needle Free Diabetes Management Market Size (2020-2031)

9.2 Latin America Needle Free Diabetes Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Needle Free Diabetes Management Market Size by Country (2020-2025)

9.4 Latin America Needle Free Diabetes Management Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Needle Free Diabetes Management Market Size (2020-2031)

10.2 Middle East & Africa Needle Free Diabetes Management Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Needle Free Diabetes Management Market Size by Country (2020-2025)

10.4 Middle East & Africa Needle Free Diabetes Management Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zogenix

11.1.1 Zogenix Company Details

11.1.2 Zogenix Business Overview

11.1.3 Zogenix Needle Free Diabetes Management Introduction

11.1.4 Zogenix Revenue in Needle Free Diabetes Management Business (2020-2025)

11.1.5 Zogenix Recent Development

11.2 3M

11.2.1 3M Company Details

11.2.2 3M Business Overview

11.2.3 3M Needle Free Diabetes Management Introduction

11.2.4 3M Revenue in Needle Free Diabetes Management Business (2020-2025)

11.2.5 3M Recent Development

11.3 Antares Pharma Inc.

11.3.1 Antares Pharma Inc. Company Details

11.3.2 Antares Pharma Inc. Business Overview

11.3.3 Antares Pharma Inc. Needle Free Diabetes Management Introduction

11.3.4 Antares Pharma Inc. Revenue in Needle Free Diabetes Management Business (2020-2025)

11.3.5 Antares Pharma Inc. Recent Development

11.4 Glide Pharmaceutical Technologies

11.4.1 Glide Pharmaceutical Technologies Company Details

11.4.2 Glide Pharmaceutical Technologies Business Overview

11.4.3 Glide Pharmaceutical Technologies Needle Free Diabetes Management Introduction

11.4.4 Glide Pharmaceutical Technologies Revenue in Needle Free Diabetes Management Business (2020-2025)

11.4.5 Glide Pharmaceutical Technologies Recent Development

11.5 Injex Pharma AG

11.5.1 Injex Pharma AG Company Details

11.5.2 Injex Pharma AG Business Overview

11.5.3 Injex Pharma AG Needle Free Diabetes Management Introduction

11.5.4 Injex Pharma AG Revenue in Needle Free Diabetes Management Business (2020-2025)

11.5.5 Injex Pharma AG Recent Development

11.6 Pharmajet, Inc.

11.6.1 Pharmajet, Inc. Company Details

11.6.2 Pharmajet, Inc. Business Overview

11.6.3 Pharmajet, Inc. Needle Free Diabetes Management Introduction

11.6.4 Pharmajet, Inc. Revenue in Needle Free Diabetes Management Business (2020-2025)

11.6.5 Pharmajet, Inc. Recent Development

11.7 Bioject Medical Technologies

11.7.1 Bioject Medical Technologies Company Details

11.7.2 Bioject Medical Technologies Business Overview

11.7.3 Bioject Medical Technologies Needle Free Diabetes Management Introduction

11.7.4 Bioject Medical Technologies Revenue in Needle Free Diabetes Management Business (2020-2025)

11.7.5 Bioject Medical Technologies Recent Development

11.8 Medtronic

11.8.1 Medtronic Company Details

11.8.2 Medtronic Business Overview

11.8.3 Medtronic Needle Free Diabetes Management Introduction

11.8.4 Medtronic Revenue in Needle Free Diabetes Management Business (2020-2025)

11.8.5 Medtronic Recent Development

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Details

11.9.2 Johnson & Johnson Business Overview

11.9.3 Johnson & Johnson Needle Free Diabetes Management Introduction

11.9.4 Johnson & Johnson Revenue in Needle Free Diabetes Management Business (2020-2025)

11.9.5 Johnson & Johnson Recent Development

11.10 Pancreum LLC

11.10.1 Pancreum LLC Company Details

11.10.2 Pancreum LLC Business Overview

11.10.3 Pancreum LLC Needle Free Diabetes Management Introduction

11.10.4 Pancreum LLC Revenue in Needle Free Diabetes Management Business (2020-2025)

11.10.5 Pancreum LLC Recent Development

11.11 Tandem Diabetes Care

11.11.1 Tandem Diabetes Care Company Details

11.11.2 Tandem Diabetes Care Business Overview

11.11.3 Tandem Diabetes Care Needle Free Diabetes Management Introduction

11.11.4 Tandem Diabetes Care Revenue in Needle Free Diabetes Management Business (2020-2025)

11.11.5 Tandem Diabetes Care Recent Development

11.12 JDRF

11.12.1 JDRF Company Details

11.12.2 JDRF Business Overview

11.12.3 JDRF Needle Free Diabetes Management Introduction

11.12.4 JDRF Revenue in Needle Free Diabetes Management Business (2020-2025)

11.12.5 JDRF Recent Development

11.13 Akra Dermojet

11.13.1 Akra Dermojet Company Details

11.13.2 Akra Dermojet Business Overview

11.13.3 Akra Dermojet Needle Free Diabetes Management Introduction

11.13.4 Akra Dermojet Revenue in Needle Free Diabetes Management Business (2020-2025)

11.13.5 Akra Dermojet Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Zogenix

Antares Pharma, Inc.

Glide Pharmaceutical Technologies

Injex Pharma AG

PharmaJet

Bioject Medical Technologies

List of Tables

Table 1. Global Needle Free Diabetes Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Insulin Jet Injector

Table 3. Key Players of Insulin Pen

Table 4. Key Players of Insulin Inhaler

Table 5. Key Players of Insulin Patch & Pump

Table 6. Global Needle Free Diabetes Management Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Needle Free Diabetes Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Needle Free Diabetes Management Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Needle Free Diabetes Management Market Share by Region (2020-2025)

Table 10. Global Needle Free Diabetes Management Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Needle Free Diabetes Management Market Share by Region (2026-2031)

Table 12. Needle Free Diabetes Management Market Trends

Table 13. Needle Free Diabetes Management Market Drivers

Table 14. Needle Free Diabetes Management Market Challenges

Table 15. Needle Free Diabetes Management Market Restraints

Table 16. Global Needle Free Diabetes Management Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Needle Free Diabetes Management Market Share by Players (2020-2025)

Table 18. Global Top Needle Free Diabetes Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle Free Diabetes Management as of 2024)

Table 19. Ranking of Global Top Needle Free Diabetes Management Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Needle Free Diabetes Management Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Needle Free Diabetes Management, Headquarters and Area Served

Table 22. Global Key Players of Needle Free Diabetes Management, Product and Application

Table 23. Global Key Players of Needle Free Diabetes Management, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Needle Free Diabetes Management Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Needle Free Diabetes Management Revenue Market Share by Type (2020-2025)

Table 27. Global Needle Free Diabetes Management Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Needle Free Diabetes Management Revenue Market Share by Type (2026-2031)

Table 29. Global Needle Free Diabetes Management Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Needle Free Diabetes Management Revenue Market Share by Application (2020-2025)

Table 31. Global Needle Free Diabetes Management Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Needle Free Diabetes Management Revenue Market Share by Application (2026-2031)

Table 33. North America Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Needle Free Diabetes Management Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Needle Free Diabetes Management Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Needle Free Diabetes Management Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Needle Free Diabetes Management Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Needle Free Diabetes Management Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Needle Free Diabetes Management Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Needle Free Diabetes Management Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Needle Free Diabetes Management Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Needle Free Diabetes Management Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Needle Free Diabetes Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Needle Free Diabetes Management Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Needle Free Diabetes Management Market Size by Country (2026-2031) & (US$ Million)

Table 48. Zogenix Company Details

Table 49. Zogenix Business Overview

Table 50. Zogenix Needle Free Diabetes Management Product

Table 51. Zogenix Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 52. Zogenix Recent Development

Table 53. 3M Company Details

Table 54. 3M Business Overview

Table 55. 3M Needle Free Diabetes Management Product

Table 56. 3M Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 57. 3M Recent Development

Table 58. Antares Pharma Inc. Company Details

Table 59. Antares Pharma Inc. Business Overview

Table 60. Antares Pharma Inc. Needle Free Diabetes Management Product

Table 61. Antares Pharma Inc. Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 62. Antares Pharma Inc. Recent Development

Table 63. Glide Pharmaceutical Technologies Company Details

Table 64. Glide Pharmaceutical Technologies Business Overview

Table 65. Glide Pharmaceutical Technologies Needle Free Diabetes Management Product

Table 66. Glide Pharmaceutical Technologies Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 67. Glide Pharmaceutical Technologies Recent Development

Table 68. Injex Pharma AG Company Details

Table 69. Injex Pharma AG Business Overview

Table 70. Injex Pharma AG Needle Free Diabetes Management Product

Table 71. Injex Pharma AG Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 72. Injex Pharma AG Recent Development

Table 73. Pharmajet, Inc. Company Details

Table 74. Pharmajet, Inc. Business Overview

Table 75. Pharmajet, Inc. Needle Free Diabetes Management Product

Table 76. Pharmajet, Inc. Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 77. Pharmajet, Inc. Recent Development

Table 78. Bioject Medical Technologies Company Details

Table 79. Bioject Medical Technologies Business Overview

Table 80. Bioject Medical Technologies Needle Free Diabetes Management Product

Table 81. Bioject Medical Technologies Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 82. Bioject Medical Technologies Recent Development

Table 83. Medtronic Company Details

Table 84. Medtronic Business Overview

Table 85. Medtronic Needle Free Diabetes Management Product

Table 86. Medtronic Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 87. Medtronic Recent Development

Table 88. Johnson & Johnson Company Details

Table 89. Johnson & Johnson Business Overview

Table 90. Johnson & Johnson Needle Free Diabetes Management Product

Table 91. Johnson & Johnson Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 92. Johnson & Johnson Recent Development

Table 93. Pancreum LLC Company Details

Table 94. Pancreum LLC Business Overview

Table 95. Pancreum LLC Needle Free Diabetes Management Product

Table 96. Pancreum LLC Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 97. Pancreum LLC Recent Development

Table 98. Tandem Diabetes Care Company Details

Table 99. Tandem Diabetes Care Business Overview

Table 100. Tandem Diabetes Care Needle Free Diabetes Management Product

Table 101. Tandem Diabetes Care Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 102. Tandem Diabetes Care Recent Development

Table 103. JDRF Company Details

Table 104. JDRF Business Overview

Table 105. JDRF Needle Free Diabetes Management Product

Table 106. JDRF Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 107. JDRF Recent Development

Table 108. Akra Dermojet Company Details

Table 109. Akra Dermojet Business Overview

Table 110. Akra Dermojet Needle Free Diabetes Management Product

Table 111. Akra Dermojet Revenue in Needle Free Diabetes Management Business (2020-2025) & (US$ Million)

Table 112. Akra Dermojet Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Needle Free Diabetes Management Picture

Figure 2. Global Needle Free Diabetes Management Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Needle Free Diabetes Management Market Share by Type: 2024 VS 2031

Figure 4. Insulin Jet Injector Features

Figure 5. Insulin Pen Features

Figure 6. Insulin Inhaler Features

Figure 7. Insulin Patch & Pump Features

Figure 8. Global Needle Free Diabetes Management Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Needle Free Diabetes Management Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Other Case Studies

Figure 13. Needle Free Diabetes Management Report Years Considered

Figure 14. Global Needle Free Diabetes Management Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Needle Free Diabetes Management Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Needle Free Diabetes Management Market Share by Region: 2024 VS 2031

Figure 17. Global Needle Free Diabetes Management Market Share by Players in 2024

Figure 18. Global Top Needle Free Diabetes Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle Free Diabetes Management as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Needle Free Diabetes Management Revenue in 2024

Figure 20. North America Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Needle Free Diabetes Management Market Share by Country (2020-2031)

Figure 22. United States Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Needle Free Diabetes Management Market Share by Country (2020-2031)

Figure 26. Germany Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Needle Free Diabetes Management Market Share by Region (2020-2031)

Figure 34. China Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Needle Free Diabetes Management Market Share by Country (2020-2031)

Figure 42. Mexico Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Needle Free Diabetes Management Market Share by Country (2020-2031)

Figure 46. Turkey Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Needle Free Diabetes Management Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Zogenix Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 50. 3M Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 51. Antares Pharma Inc. Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 52. Glide Pharmaceutical Technologies Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 53. Injex Pharma AG Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 54. Pharmajet, Inc. Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 55. Bioject Medical Technologies Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 56. Medtronic Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 57. Johnson & Johnson Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 58. Pancreum LLC Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 59. Tandem Diabetes Care Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 60. JDRF Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 61. Akra Dermojet Revenue Growth Rate in Needle Free Diabetes Management Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Digital Diabetes Management Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions